EP4085256C0 - Test et diagnostic in vitro du syndrome de l'intestin irritable - Google Patents

Test et diagnostic in vitro du syndrome de l'intestin irritable

Info

Publication number: EP4085256C0
Authority: EP; European Patent Office
Prior art keywords: irgitable; test; bowel syndrome; vitro diagnosis; vitro
Prior art date: 2020-01-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

EP21702612.9A

Other languages

German (de)

English (en)

Other versions

EP4085256B1 (fr

EP4085256A1 (fr

Inventor

Franz Paul Armbruster

Sonja Bastian

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Immundiagnostik AG

Original Assignee

Immundiagnostik AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2020-01-27

Filing date

2021-01-27

Publication date

2024-01-24

2021-01-27 Application filed by Immundiagnostik AG filed Critical Immundiagnostik AG

2022-11-09 Publication of EP4085256A1 publication Critical patent/EP4085256A1/fr

2024-01-24 Application granted granted Critical

2024-01-24 Publication of EP4085256B1 publication Critical patent/EP4085256B1/fr

2024-01-24 Publication of EP4085256C0 publication Critical patent/EP4085256C0/fr

Status Active legal-status Critical Current

2041-01-27 Anticipated expiration legal-status Critical

Links

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biotechnology (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Pathology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP21702612.9A 2020-01-27 2021-01-27 Test et diagnostic in vitro du syndrome de l'intestin irritable Active EP4085256B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102020101864		2020-01-27
PCT/EP2021/051858 WO2021151942A1 (fr)	2020-01-27	2021-01-27	Essai et diagnostic in vitro du syndrome du côlon irritable

Publications (3)

Publication Number	Publication Date
EP4085256A1 EP4085256A1 (fr)	2022-11-09
EP4085256B1 EP4085256B1 (fr)	2024-01-24
EP4085256C0 true EP4085256C0 (fr)	2024-01-24

Family

ID=74494881

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP21702612.9A Active EP4085256B1 (fr)	2020-01-27	2021-01-27	Test et diagnostic in vitro du syndrome de l'intestin irritable

Country Status (3)

Country	Link
US (1)	US20230074127A1 (fr)
EP (1)	EP4085256B1 (fr)
WO (1)	WO2021151942A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2764870C1 (ru) *	2021-03-30	2022-01-21	Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора)	Способ диагностики активности воспалительных заболеваний кишечника на основе совокупности электрических и вязкоупругих параметров эритроцитов
WO2025253316A1 (fr) *	2024-06-04	2025-12-11	Universidade Do Porto	Enzyme de conversion de l'angiotensine et/ou enzyme de conversion de l'angiotensine 2 utilisées en tant que biomarqueurs fécaux, procédés et utilisations associés

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5594116A (en)	1995-11-08	1997-01-14	Promega Corporation	Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay
CA2766157A1 (fr) *	2009-06-25	2010-12-29	Hua Gong	Procedes pour diagnostiquer un syndrome du colon irritable
SG11201509371XA (en)	2013-05-24	2015-12-30	Nestec Sa	Pathway specific markers for diagnosing irritable bowel syndrome

2021
- 2021-01-27 US US17/795,487 patent/US20230074127A1/en active Pending
- 2021-01-27 EP EP21702612.9A patent/EP4085256B1/fr active Active
- 2021-01-27 WO PCT/EP2021/051858 patent/WO2021151942A1/fr not_active Ceased

Also Published As

Publication number	Publication date
WO2021151942A1 (fr)	2021-08-05
EP4085256B1 (fr)	2024-01-24
EP4085256A1 (fr)	2022-11-09
US20230074127A1 (en)	2023-03-09

Legal Events

Date	Code	Title	Description
2021-02-11	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: UNKNOWN
2021-08-06	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2022-10-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2022-10-07	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2022-11-09	17P	Request for examination filed	Effective date: 20220804
2022-11-09	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2023-05-03	DAV	Request for validation of the european patent (deleted)
2023-05-03	DAX	Request for extension of the european patent (deleted)
2023-10-03	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2023-10-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2023-11-01	INTG	Intention to grant announced	Effective date: 20231004
2023-12-18	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2023-12-22	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2023-12-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE PATENT HAS BEEN GRANTED
2024-01-24	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2024-01-24	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2024-01-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2024-02-14	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2024-02-15	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602021008734 Country of ref document: DE
2024-03-13	U01	Request for unitary effect filed	Effective date: 20240205
2024-03-20	U07	Unitary effect registered	Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI Effective date: 20240219
2024-03-27	U20	Renewal fee for the european patent with unitary effect paid	Year of fee payment: 4 Effective date: 20240222
2024-04-16	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: IE Payment date: 20240214 Year of fee payment: 4
2024-07-01	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240524
2024-07-15	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240425
2024-07-18	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240424 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-07-22	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240424 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240424 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240524 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240425 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-08-01	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-08-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-08-30	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2024-10-14	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-10-21	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240131
2024-10-25	REG	Reference to a national code	Ref country code: DE Ref legal event code: R097 Ref document number: 602021008734 Country of ref document: DE
2024-10-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-10-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240131
2024-11-11	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-11-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-11-29	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2024-11-29	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2025-01-01	26N	No opposition filed	Effective date: 20241025
2025-03-05	U20	Renewal fee for the european patent with unitary effect paid	Year of fee payment: 5 Effective date: 20250127
2025-07-17	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2025-08-07	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20210127
2025-09-03	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20210127
2025-12-12	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2026-01-20	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20250127
2026-03-11	U21	Renewal fee for the european patent with unitary effect paid with additional fee	Year of fee payment: 6 Effective date: 20260204
2026-04-09	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: GB Payment date: 20260219 Year of fee payment: 6
2026-04-23	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: CZ Payment date: 20260217 Year of fee payment: 6

Publication	Publication Date	Title
EP4113122A4 (fr)	2024-04-17	Analyseur de diagnostic in vitro et carte de réactif
EP4184653A4 (fr)	2024-08-14	Procédé d'essai et procédé de fabrication
EP4126905A4 (fr)	2024-05-29	Inhibiteurs de cyclophiline et leurs utilisations
EP4564002A4 (fr)	2025-11-12	Kit, ensemble de mesure et dispositif d'analyse de gaz sanguin
EP3885761C0 (fr)	2025-08-20	Biodétecteur et procédé de mesure l'utilisant
EP4126903A4 (fr)	2024-05-08	Inhibiteurs de cyclophiline et leurs utilisations
IL289604A (en)	2022-03-01	De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
EP4159116A4 (fr)	2024-07-03	Procédé et appareil de test
EP4490182A4 (fr)	2026-03-25	Anticorps anti-cd36 et leurs utilisations
EP4368957A4 (fr)	2025-07-09	Système d'inspection et procédé d'inspection
EP4387540A4 (fr)	2025-06-18	Assemblage et conception de sonde à module multiple
EP4369056A4 (fr)	2025-07-09	Système et procédé de contrôle
EP4317404A4 (fr)	2025-04-23	Système d'inspection et procédé d'inspection
EP4308993C0 (fr)	2025-10-08	Structure d'affichage et dispositif d'affichage
EP4198040C0 (fr)	2025-07-02	Complexe pt-dpephos-iode et complexe pt-dpephos-brome
EP4143476A4 (fr)	2024-03-27	Ensemble régulateur et procédé de test
EP4551571A4 (fr)	2026-05-13	Agonistes de trpml1 oxazolique et leurs utilisations
EP4502575A4 (fr)	2026-03-11	Dispositif de détermination de sexe et procédé de détermination de sexe
EP4370705A4 (fr)	2025-05-21	Articles et procédés pour effectuer des dosages
EP4297106A4 (fr)	2024-08-28	Dispositif d'inspection et procédé d'inspection
EP4197995C0 (fr)	2025-07-09	Complexe pt-xanthène-iode et complexe pt-xanthène-brome
EP4171621A4 (fr)	2024-10-09	Cellules immunitaires exprimant c825 et utilisations diagnostiques associées
EP4571334A4 (fr)	2026-04-08	Procédé de test et système de test
EP4092136C0 (fr)	2024-02-07	Sondes de capture et leurs utilisations
EP4279927A4 (fr)	2024-08-14	Pince de détection et ensemble de détection